| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74126e5478052da77efb91870c362ed4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07a18b3df75089b798d5186465a86ae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a615b6db0acb71ee30f71f157888ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59f031838415927f1d639dd6bb03e8b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab5986a5155226b29a57908a13438d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ead21e1e810d1df210552c42769f6574 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
| filingDate |
2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b7c73bc158a32127a3b295c2e995cd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e3a620b382bdfac95d93693c2dfe786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a4787a83fd71a4b638d1dc9ad04207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4571e6a1138128bc795654cca247c9e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_595c986887d9b6e0df11f07119b840e7 |
| publicationDate |
2013-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013245052-A1 |
| titleOfInvention |
Novel polymorph of nilotinib hydrochloride |
| abstract |
The present invention provides a novel crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical compositions comprising it. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10016423-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021380557-A1 |
| priorityDate |
2010-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |